Level Biotechnology (ROCO:3118) Total Receivables: NT$162.5 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:3118 Level Biotechnology Inc ROCO:3118
76 GF Score
Price NT$31.95
GF Value NT$35.57
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Level Biotechnology Total Receivables?

Level Biotechnology ROCO:3118 +0.63% 76 Total Receivables is NT$162.5 Mil as of Dec. 2025. GuruFocus rates ROCO:3118 with a GF Score™ of 76/100 and a GF Value™ of NT$35.57 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Level Biotechnology's Total Receivables for the quarter that ended in Dec. 2025 was NT$162.5 Mil.

Level Biotechnology Total Receivables Related Terms

Level Biotechnology Total Receivables Historical Data

* Premium members only.

The historical data trend for Level Biotechnology's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Level Biotechnology Total Receivables Chart

Level Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 98.52 120.66 112.82 115.99 162.50

Level Biotechnology Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 115.99 114.04 138.65 148.94 162.50
ROCO:3118
76GF Score
Level Biotechnology Inc ROCO:3118
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Level Biotechnology Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of NT$162.5 Mil mean?
Level Biotechnology (ROCO:3118) has a Total Receivables of NT$162.5 Mil as of Dec. 2025. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Level Biotechnology and its competitors.
Is Level Biotechnology's Total Receivables too high?
Level Biotechnology's current Total Receivables is NT$162.5 Mil. Overall, Level Biotechnology has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Level Biotechnology's Total Receivables compare to VRTX and REGN?
Level Biotechnology's Total Receivables of NT$162.5 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Biotechnology company?
A good Total Receivables depends on the Biotechnology industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Level Biotechnology and its competitors. Level Biotechnology's current Total Receivables is NT$162.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Level Biotechnology stock overvalued right now?
Based on GuruFocus' analysis, Level Biotechnology (ROCO:3118) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$35.57, compared to a current price of NT$31.95 — trading 10.2% below its estimated fair value. The current Total Receivables is NT$162.5 Mil. Level Biotechnology's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Level Biotechnology (ROCO:3118), the current Total Receivables is NT$162.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Level Biotechnology (ROCO:3118) Overvalued in 2026?

Based on GuruFocus' analysis, Level Biotechnology stock appears to be undervalued. The current stock price of NT$31.95 is trading 10.2% below its estimated GF Value™ of NT$35.57. GuruFocus considers Level Biotechnology to be Modestly Undervalued.

Key valuation signals for ROCO:3118:

  • Total Receivables: NT$162.5 Mil
  • GF Value™: NT$35.57 vs. price of NT$31.95 (10.2% below fair value)
  • GF Score™: 76/100 with 2 warning signs

No single metric tells the full story. See the ROCO:3118 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Level Biotechnology Business Description

Address No. 80, Lane 169, Kangning Street, Xizhi District, New Taipei City, TWN, 221
Level Biotechnology Inc is a Taiwan-based company engaged in the sales of biomedical products and providing preclinical testing services. The company has three reportable segments: Department A and B, Department C, and Department D. Department A and Department B sell the cell culture consumables and the antibody reagents, Department C sells the instruments and equipment, and Department D provides CRO services. The majority of revenue is derived from the Department A and B.
76GF Score

Get the complete analysis for ROCO:3118

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.95
Price
NT$35.57
GF Value